MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617074226 A) filed by Eli Lilly And Company on June 15, 2026, for Benzothiazole Derivatives Useful As Rxfp1 Receptor Agonists.
Inventors include Anderson, Erin; Fields, Todd; Flynn, Autumn Rose; Mckenney Hall, Megan; Johnston, Richard Duane; Lamar, Jason Eric; Mayne, Christopher Number; Mcfaddin, Elizabeth; Metcalf, Andrew; Sammakia, Tarek; and Sun, Zhicheng.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention provides compounds of the formula (I): Formula (I) wherein Ring A, R1, R2, and R3 are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and pharmaceutically acceptable salts thereof for treating patients for cardiovascular, pulmonary and/or renal conditions, diseases and/or disorders.
Disclaimer: Curated by HT Syndication.
